Patent classifications
G01N30/14
Packed Tip Electrospray Emitter
Packed-tip electrospray ionization (ESI) emitters for mass spectrometry are described. In one aspect an ESI emitter stores a first type of particle. A liquid chromatography (LC) column is coupled with the emitter via a junction. The LC column stores a different type of particle than the ESI emitter to facilitate better chromatographic and ESI performance.
SIZE EXCLUSION CHROMATOGRAPHY COLUMN TECHNOLOGIES FOR ANALYSIS OF CRISPR MOLECULES
The present disclosure is directed to methods for performing size exclusion chromatographic (SEC) separations. Embodiments of the present disclosure feature methods for improved separations of biomolecule analytes, such as CRISPR-related proteins, nucleotides, and ribonucleoprotein complexes, in SEC, for example, by using hydroxy-terminated polyethylene glycol surface modified stationary phase materials and/or C2/PEG surface modified column hardware.
SIZE EXCLUSION CHROMATOGRAPHY COLUMN TECHNOLOGIES FOR ANALYSIS OF CRISPR MOLECULES
The present disclosure is directed to methods for performing size exclusion chromatographic (SEC) separations. Embodiments of the present disclosure feature methods for improved separations of biomolecule analytes, such as CRISPR-related proteins, nucleotides, and ribonucleoprotein complexes, in SEC, for example, by using hydroxy-terminated polyethylene glycol surface modified stationary phase materials and/or C2/PEG surface modified column hardware.
METHOD FOR ANALYZING DIFFERENTIATION OF METABOLITES IN URINE SAMPLE BETWEEN DIFFERENT GROUPS
The present invention relates to a method for metabolite sampling and analysis for reproducibly sampling as many metabolites as possible in a urine sample without changing to metabolites. The method has effects of presenting a biomarker detection method according to the sex or the like, by establishing optimal conditions for metabolite sampling in urine samples and presenting a metabolite comparison analysis method between different groups on the basis of the optimal conditions.
METHOD FOR ANALYZING DIFFERENTIATION OF METABOLITES IN URINE SAMPLE BETWEEN DIFFERENT GROUPS
The present invention relates to a method for metabolite sampling and analysis for reproducibly sampling as many metabolites as possible in a urine sample without changing to metabolites. The method has effects of presenting a biomarker detection method according to the sex or the like, by establishing optimal conditions for metabolite sampling in urine samples and presenting a metabolite comparison analysis method between different groups on the basis of the optimal conditions.
Proteoform Specific Process Validation
A system and method is provided for validating the manufacturing process for the production of complex biological compositions, and particularly for providing process validation information for evaluation by a federal regulatory agency. The system and method continuously and chronologically assess the concentration of proteoforms within the biological composition as it is being produced in a fermentor. Samples from the fermentor are analyzed in a pre-selected array of analysis columns, with data generated by the columns being accumulated and evaluated, and particularly compared with data from previous stages in the production process. A continuous process validation system includes top-down and bottom-up analysis sectors, each including a plurality of different analysis columns that can be selected by the controller for a particular biological composition and a particular production process.
Proteoform Specific Process Validation
A system and method is provided for validating the manufacturing process for the production of complex biological compositions, and particularly for providing process validation information for evaluation by a federal regulatory agency. The system and method continuously and chronologically assess the concentration of proteoforms within the biological composition as it is being produced in a fermentor. Samples from the fermentor are analyzed in a pre-selected array of analysis columns, with data generated by the columns being accumulated and evaluated, and particularly compared with data from previous stages in the production process. A continuous process validation system includes top-down and bottom-up analysis sectors, each including a plurality of different analysis columns that can be selected by the controller for a particular biological composition and a particular production process.
PREPARATIVE FLUID CHROMATOGRAPH DEVICE
A fraction collector (14) that is provided downstream of a detector (10) and for separating an eluate eluted from a separation column (8) into a plurality of parts and collecting each of the parts into a plurality of containers respectively, and a controller (16) configured to execute fractionation operation for each sample injected at one time into the mobile phase are provided. In the fractionation operation, the controller detects components separated from each other in the separation column (8) as peaks individually based on a signal output from the detector (10), and controls operation of the fraction collector (14) such that the components detected as the peaks are collected in different containers. The controller (16) is configured to set a reference number of the number of components in a sample injected into the mobile phase, to count the number of components detected as the peaks for each sample injected into the mobile phase at a time by the injector (6), and to determine that the fractionation operation of the sample is completed when the number of components counted reaches the reference number and all components as many as the reference number are collected in the container.
PREPARATIVE FLUID CHROMATOGRAPH DEVICE
A fraction collector (14) that is provided downstream of a detector (10) and for separating an eluate eluted from a separation column (8) into a plurality of parts and collecting each of the parts into a plurality of containers respectively, and a controller (16) configured to execute fractionation operation for each sample injected at one time into the mobile phase are provided. In the fractionation operation, the controller detects components separated from each other in the separation column (8) as peaks individually based on a signal output from the detector (10), and controls operation of the fraction collector (14) such that the components detected as the peaks are collected in different containers. The controller (16) is configured to set a reference number of the number of components in a sample injected into the mobile phase, to count the number of components detected as the peaks for each sample injected into the mobile phase at a time by the injector (6), and to determine that the fractionation operation of the sample is completed when the number of components counted reaches the reference number and all components as many as the reference number are collected in the container.
LAMP-HOUSING ASSEMBLY WITH AXIALLY AND RADIALLY ALIGNED AND ELECTRICALLY COUPLED ELEMENTS
A lamp-housing assembly, for a detector of a sample separation apparatus for separating a fluidic sample, includes a lamp seat, a lamp insertable into the lamp seat, and a lamp cap mountable on the lamp seat and on the inserted lamp. The lamp seat, lamp and lamp cap are matched with respect to each other so that, by inserting the lamp into the lamp seat and by mounting the lamp cap on the lamp seat and on the inserted lamp, the lamp is axially and radially aligned and electrically and thermally coupled with the lamp seat and the lamp cap.